More on GANX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (8.8 Score)
- Holders

Upcoming Events

- Earnings (8/6/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Gain Therapeutics (NQ:GANX)
Delayed: 1.88 +0.10 (5.62%)
Prev. Close $1.78  
Open$1.81 
52 Wk High$ 
52 Wk Low$ 
Day High$1.90 
Day Low$1.80 
P/E N/A  
EPS$ 
Volume503,934 


Jun 10, 2026 07:00 AM Gain Therapeutics to Present at H.C. Wainwright 7th Annual Neuro Perspectives Expert Summit
May 27, 2026 04:28 AM Oppenheimer on Gain Therapeutics (GANX): 'Ph2a study initiation remains on track for 3Q26'
May 26, 2026 09:26 AM Form 8-K Gain Therapeutics, Inc. For: May 26
May 26, 2026 08:01 AM Gain Therapeutics reports interim data from Parkinson's disease study
May 26, 2026 08:00 AM Gain Therapeutics Presents Positive Interim Data from Phase 1b Clinical Study of GT-02287 at 3rd International GBA1 Meeting 2026
May 11, 2026 04:09 PM Form 10-Q Gain Therapeutics, Inc. For: Mar 31
May 11, 2026 04:06 PM Form 8-K Gain Therapeutics, Inc. For: May 11
May 11, 2026 07:22 AM Gain Therapeutics, Inc. (GANX) Tops Q1 EPS by 1c
May 11, 2026 07:00 AM Gain Therapeutics Reports Financial Results for First Quarter 2026 and Provides Corporate Update
Apr 28, 2026 04:50 PM Form ARS Gain Therapeutics, Inc. For: Dec 31
View All Articles

Entities mentioned with GANX

View All Entities